Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Shares Outstanding (Weighted Average): 2019-2024

Historic Shares Outstanding (Weighted Average) for ADC Therapeutics (ADCT) over the last 6 years, with Dec 2024 value amounting to $96.7 million.

  • ADC Therapeutics' Shares Outstanding (Weighted Average) rose 2.23% to $82.3 million in Q4 2023 from the same period last year, while for Sep 2023 it was $81.5 million, marking a year-over-year change of. This contributed to the annual value of $96.7 million for FY2024, which is 17.55% up from last year.
  • As of FY2024, ADC Therapeutics' Shares Outstanding (Weighted Average) stood at $96.7 million, which was up 17.55% from $82.3 million recorded in FY2023.
  • ADC Therapeutics' Shares Outstanding (Weighted Average)'s 5-year high stood at $96.7 million during FY2024, with a 5-year trough of $70.9 million in FY2020.
  • In the last 3 years, ADC Therapeutics' Shares Outstanding (Weighted Average) had a median value of $82.3 million in 2023 and averaged $86.5 million.
  • Data for ADC Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY climbed of 17.55% (in 2024) over the last 5 years.
  • ADC Therapeutics' Shares Outstanding (Weighted Average) (Yearly) stood at $70.9 million in 2020, then increased by 8.21% to $76.7 million in 2021, then increased by 4.85% to $80.5 million in 2022, then rose by 2.23% to $82.3 million in 2023, then grew by 17.55% to $96.7 million in 2024.